Welcome to our dedicated page for Nutanix SEC filings (Ticker: NTNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nutanix, Inc. (NASDAQ: NTNX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Nutanix is a hybrid multicloud software company, and its filings offer detailed insight into how it describes its cloud platform, subscription business model, governance practices, and capital allocation decisions.
Investors can review Form 10-K annual reports and Form 10-Q quarterly reports for management’s discussion of Nutanix’s hybrid multicloud strategy, its Nutanix Cloud Platform and related offerings, and key risk factors. Current reports on Form 8-K document specific material events, such as the announcement of accelerated share repurchase agreements, updates to equity incentive plans, executive and director compensation decisions, quarterly and annual financial results, and board appointments.
This page also surfaces proxy materials such as the DEF 14A definitive proxy statement, where Nutanix discusses topics including its evolution into a broader cloud platform company, its vision for running applications and AI and managing data anywhere, and proposals related to director elections, auditor ratification, advisory votes on executive compensation, and equity plan amendments.
Stock Titan enhances these NTNX filings with AI-powered summaries that explain the contents of lengthy documents in accessible language. Users can quickly understand the significance of complex items in 10-Ks and 10-Qs, follow executive and director compensation arrangements described in proxy statements and 8-Ks, and track ongoing capital return programs and other corporate actions disclosed in current reports. Real-time updates from EDGAR ensure that new Nutanix filings, including any Form 4 insider transaction reports or additional 8-Ks, appear promptly with AI-generated context.
Nutanix, Inc. reported a proposed sale of 144,707 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $11,059,204.05. The filing lists the approximate sale date as 10/02/2025 on NASDAQ. The shares to be sold were acquired from multiple compensation events: performance shares granted on 03/15/2024 (14,346 shares) and 09/15/2024 (89,394 shares), restricted stock grants on 03/15/2024 (25,159 shares) and 09/15/2025 (2,318 shares), an employee purchase on 03/20/2024 (741 shares) paid in cash, and additional performance shares on 09/15/2025 (12,749 shares). The filing states no securities were sold by the person in the prior three months and includes the standard representation about no undisclosed material adverse information.
Nutanix, Inc. reported a proposed sale of 3,500 shares of its Common stock on a Form 144 filed as a live submission. The shares were acquired as Restricted Stock from the Issuer on 12/08/2024 and the filing lists an approximate sale date of 10/02/2025. The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services and the aggregate market value of the planned sale is reported as $267,690.85. The filing also discloses 268,800,007 shares outstanding and states there were no securities sold in the past three months by the reporting person.
Nutanix, Inc. (NTNX) Form 4: Chief Legal Officer Brian Martin reported sales and remaining holdings on 09/30/2025. He sold 10,241 shares of Class A common stock in multiple transactions at a weighted average price of $76.5288 per share under a Rule 10b5-1 trading plan adopted July 1, 2025. Following the reported sale, the filing shows 5,166 shares beneficially owned. The report also notes acquisition of 229 shares under the company Employee Stock Purchase Plan on 09/22/2025. The Form 4 was signed by an attorney-in-fact, Raymond Hum.
Form 144 filed for Nutanix, Inc. (NTNX) reporting a proposed sale of 10,241 common shares through Morgan Stanley Smith Barney LLC on 09/30/2025 on NASDAQ, with an aggregate market value of $783,731.44. The filing shows the shares were acquired on 09/15/2025 from the issuer as restricted stock (5,561 shares) and performance shares (4,680 shares). No securities were reported sold in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.
Nutanix reported continued subscription-led growth and updated capital allocation authority. Subscription revenue classified as ratable and upfront rose materially: ratable subscription components were $905.8M, $1,029.0M and $1,138.4M for fiscal 2023–2025, while upfront subscription software license revenue was $825.0M, $987.8M and $1,272.4M for the same years, showing strong year‑over‑year increases.
The Board expanded the share repurchase program: an initial $350.0M authorization from August 2023 was increased by $350.0M in August 2025, with no expiration and repurchases to occur at management discretion. Unbilled accounts receivable were $41.1M and $83.5M as of July 31, 2024 and 2025, respectively. Non‑portable software revenue declined from $37.4M (2023) to $10.8M (2025). The filing discloses low effective interest rates on convertible notes (0.52% for 2027 Notes; 0.93% for 2029 Notes) and $500.0M principal outstanding of the 2027 Notes after a stated transaction.
Robert G. Lavender, a director of Nutanix, Inc. (NTNX), was granted restricted stock units (RSUs) that cover 843 shares of Class A common stock. The RSUs were issued on 09/17/2025 at no cash price and remain unvested. They vest in full on the earlier of (i) the day before the next annual meeting of shareholders after the grant date or (ii) the one-year anniversary of the grant, provided the reporting person continues service through the applicable vesting date. The Form 4 was filed on 09/19/2025 by an attorney-in-fact.
Robert G. Lavender, identified as a director of Nutanix, Inc. (NTNX), submitted an initial Form 3 reporting his relationship to the issuer and providing a business address in San Jose, CA. The filing states no securities are beneficially owned by the reporting person. The form was filed individually and includes a power of attorney signature on behalf of Mr. Lavender.
Nutanix, Inc. reported that its board appointed Greg Lavender as a director and member of the board’s Security and Privacy Committee, effective September 17, 2025.
The board determined that Mr. Lavender is an independent director under Nasdaq rules. He will receive the standard cash and equity compensation provided to Nutanix’s non-employee directors and enter into the company’s customary indemnification agreement for directors and executive officers. Nutanix also issued a press release about his appointment, filed as Exhibit 99.1.
Nutanix, Inc. (NTNX) Chief Legal Officer Brian Martin reported the vesting and partial disposition of restricted stock units on 09/15/2025. A grant of 11,300 RSUs vested and were reported as acquired at $0 per share, increasing his direct beneficial ownership to 33,899 Class A shares. To cover tax withholding from the vesting, 11,503 shares were sold at $78.21 per share, leaving 15,178 Class A shares directly held following the sale. The filing notes the RSU vesting schedule: 25% vested on 09/15/2025 and the remainder vests quarterly in 1/16th increments subject to continued service.
Rajiv Ramaswami, President and CEO of Nutanix (NTNX), reported multiple transactions tied to vesting of restricted stock units (RSUs) dated 09/15/2025. Several RSU grants converted into Class A common stock: 8,628; 17,206; 15,884; and 8,508 shares were reported as acquired. The filing also shows 175,811 Class A shares were disposed of at $78.21 per share, described as shares withheld to satisfy tax-withholding obligations on RSU vesting. After these transactions, the reporting person beneficially owned 669,225 Class A shares following the withholding sale, and larger totals are shown after other vested tranches. The RSUs vest in 16 equal quarterly installments for each grant, subject to continued service.